Potential use of animal models to examine antipsychotic prophylaxis for schizophrenia

Clinical Neuroscience Research

Volumn 3, Issue 4-5, 2003, Pages 289-296

  Powell, Susan B ^a   Risbrough, Victoria B ^b   Geyer, Mark A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotics; Development; Prepulse inhibition; Prodromal; Prophylactic treatment; Rodent; Schizophrenia; Sensorimotor gating

Indexed keywords

NEUROLEPTIC AGENT;

ANIMAL BEHAVIOR; ANIMAL MODEL; CHEMOPROPHYLAXIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GENETIC MANIPULATION; GENETIC RISK; NERVE CELL DIFFERENTIATION; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SCHIZOPHRENIA; SYMPTOM;

EID: 0345330039     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(03)00089-6     Document Type: Review

References (113)

1. Lieberman J.A. Fenton W.S. Delayed detection of psychosis: causes, consequences, and effect of public health Am J Psychiatry 157 2000 1727-1730
2. Wyatt R.J. Henter I.D. Rationale for the study of early intervention Schizophr Res 51 2001 69-76
3. Browne S. Clarke M. Gervin M. Waddington J.L. Larkin C. O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia Br J Psychiatry 176 2000 173-176
4. Rosen J.L. Woods S.W. Miller T.J. McGlashan T.H. Prospective observations of emerging psychosis J Nerv Ment Dis 190 2002 133-141
5. McGlashan T.H. Psychosis treatment prior to psychosis onset: ethical issues Schizophr Res 51 2001 47-54
6. McGlashan R.H. Johannessen J.O. Early detection and intervention with schizophrenia: rationale Schizophr Bull 22 1996 201-222
7. McGorry P.D. Yung A. Phillips L. Ethics and early intervention in psychosis: keeping up the pace and staying in step Schizophr Res 51 2001 17-29
8. McGorry P.D. Edwards J. Mihalopoulos C. Harrigan S. Jackson H.J. The early psychosis prevention and intervention center (EPPIC): an evolving system of early detection and optimal management Schizophr Bull 22 1996 305-326
9. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed 1994 American Psychiatric Association Washington, DC
10. Schaffner K.F. McGorry P.D. Preventing severe mental illnesses - new prospects and ethical challenges Schizophr Res 51 2001 3-15
11. Hafner H. Loffler W. Maurer K. Hambrecht M. van der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia Acta Psychiatr Scand 100 1999 105-118
12. Gottesman I.I. Schizophrenia genesis 1991 Freeman New York
13. Holzman P.S. Matthysse S. The genetics of schizophrenia: a review Pscyhol Sci 1 5 1990 279-286
14. Cornblatt B.A. Lencz T. Kane J.M. Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res 51 2001 31-38
15. Larsen T.K. Friis S. Haahr U. et al. Early detection and intervention in first-episode schizophrenia: a critical review [comment] Acta Psychiatr Scand 103 2001 321-322
16. Cornblatt B.A. Obuchowski M. Roberts S. Pollack S. Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia Dev Psychopathol 11 1999 487-508
17. Braff D.L. Information processing and attention dysfunctions in schizophrenia Schizophr Bull 19 1993 233-259
18. Kietzman M. Spring B. Zubin J. Perception, cognition, and information processing In: Kaplan H. Sadock B. editors. Comprehensive textbook in psychiatry IV 1985 157-178 Williams and Wilkins Baltimore, MD
19. Braff D.L. Geyer M.A. Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 2001 234-258
20. Cromwell R.L. Attention and information processing in schizophrenia J Psychiatr Res 14 1978 327-331
21. Grillon C. Courchesne E. Ameli R. Geyer M.A. Braff D.L. Increased distractibility in schizophrenic patients: Electrophysiological and behavioral evidence Arch Gen Psychiatry 47 1990 171-179
22. McGhie A. Chapman J. Disorders of attention and perception in early schizophrenia Br J Med Psychol 34 1961 102-116
23. Swerdlow N.R. Benbow C.H. Ziszook S. Geyer M.A. Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder Biol Psychiatry 33 1993 298-301
24. Swerdlow N.R. Paulsen J. Braff D.L. Butters N. Geyer M.A. Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease J Neurol Neurosurg Psychiatry 58 1995 192-200
25. Ornitz E.M. Hanna G.L. de Traversay J. Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis Psychophysiology 29 1992 437-451
26. Castellanos F.X. Fine E.J. Kaysen D.L. et al. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results Biol Psychiatry 39 1996 33-41
27. O'Donnell P. Grace A.A. Dysfunction in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters Schizophr Bull 24 1998 267-283
28. Swerdlow N.R. Geyer M.A. Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology 156 2001 194-215
29. Hoffman H.S. Searle J.L. Acoustic and temporal factors in the evocation of startle J Acoust Soc Am 43 1968 269-282
30. Ison J.R. McAdam D.W. Hammond G.R. Latency and amplitude changes in the acoustic startle reflex produced by variations in auditory prestimulation Physiol Behav 10 1973 1035-1039
31. Ison J.R. Hoffman H.S. Reflex modulation in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon Psychol Bull 94 1983 3-17
32. Graham F. The more or less startling effects of weak prestimulation Psychophysiology 12 1975 238-248
33. Davis M. The mammalian startle response In: Eaton R.C. editor. Neural mechanisms of startle behavior 1984 287-342 Plenum New York
34. Geyer M.A. Krebs-Thomson K. Braff D.L. Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117-154
35. Braff D.L. Stone C. Callaway E. Geyer M. Glick I. Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics Psychophysiology 15 1978 339-343
36. Cadenhead K.S. Geyer M.A. Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder Am J Psychiatry 150 1993 1862-1867
37. Cadenhead K.S. Swerdlow N.R. Shafer K.M. Diaz M. Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits Am J Psychiatry 157 2000 1660-1668
38. Cadenhead K.S. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome Psychiatr Clin North Am 25 2002 837-853
39. Cadenhead K.S. Braff D.L. Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum Schizophr Res 54 2002 47-57
40. Bredgaard R. Glenthoj B.Y. Information processing and attentional dysfunctions as vulnerability indicators in schizophrenia spectrum disorders World J Biol Psychiatry 1 2000 5-15
41. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia Arch Gen Psychiatry 44 1987 660-669
42. Murray R.M. Lewis S.W. Is schizophrenia a neurodevelopmental disorder? [letter] Br Med J (Clin Res Ed) 296 1988 63
43. Arnold S.E. Hyman B.T. van Hoesen G.W. Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia Arch Gen Psychiatry 48 1991 625-632
44. Mednick S.A. Machon R.A. Huttunen M.O. Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic Arch Gen Psychiatry 45 1988 189-192
45. O'Callaghan E. Sham P. Takei N. Glover G. Murray R.M. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic Lancet 337 1991 1248-1250
46. Takei N. Lewis S. Jones P. Harvey I. Murray R.M. Prenatal exposure to influenza and increased cerebrospinal fluid spaces in schizophrenia Schizophr Bull 22 3 1996 521-534
47. Owen M.J. Lewis S.W. Murray R.M. Obstetric complications and schizophrenia: a computed tomographic study Psychol Med 18 1988 331-339
48. Lipska B.K. Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test Neuropsychopharmacology 23 2000 223-239
49. Geyer M.A. Markou A. Animal models of psychiatric disorders In: Bloom F.E. Kupfer D. editors. Psychopharmacology: the fourth generation of progress 1995 787-798 Raven New York
50. Geyer M.A. Krebs-Thomson K. Braff D.L. Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 2001 117-154
51. Vaillancourt C. Boksa P. Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia Neuropsychopharmacology 23 2000 654-666
52. Ellenbroek B.A. van den Kroonenberg P.T. Cools A.R. The effects of an early stressful life event on sensorimotor gating in adult rats Schizophr Res 30 1998 251-260
53. Weiss I.C. Feldon J. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review Psychopharmacology (Berl) 156 2001 305-326
54. Ossowska K. Pietraszek M. Wardas J. Nowak G. Wolfarth S. Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats Naunyn Schmiedebergs Arch Pharmacol 359 1999 280-287
55. Andersson C. Hamer R.M. Lawler C.P. Mailman R.B. Lieberman J.A. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs Neuropsychopharmacology 27 2002 143-151
56. Martinez Z.A. Platten A. Pollack E. et al. 'Typical' but not 'atypical' antipsychotic effects on startle gating deficits in prepubertal rats Psychopharmacology (Berl) 161 1 2002 38-46
57. Swerdlow N.R. Braff D.L. Taaid N. Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients Arch Gen Psychiatry 51 1994 139-154
58. Brown A.S. Susser E.S. In utero infection and adult schizophrenia Ment Retard Dev Disab Res Rev 8 2002 51-57
59. Buka S.L. Tsuang M.T. Torrey E.F. Klebanoff M.A. Wagner R.L. Yolken R.H. Maternal cytokine levels during pregnancy and adult psychosis Brain Behav Immun 15 4 2001 411-420
60. Schwarz M.J. Muller N. Riedel M. Ackenheil M. The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms Med Hypotheses 56 4 2001 483-486
61. Rothschild D.M. O'Grady M. Wecker L. Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: implications for schizophrenia J Neurosci Res 57 4 1999 429-434
62. Shi L. Fatemi S.H. Sidwell R.W. Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring J Neurosci 23 1 2003 297-302
63. Borrell J. Vela J.M. Arevalo-Martin A. Molina-Holgado E. Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia Neuropsychopharmacology 26 2002 204-215
64. Petitto J.M. McNamara R.K. Gendreau P.L. Huang Z. Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion J Neurosci Res 56 1999 441-446
65. Maes M. Bocchio Chiavetto L. Bignotti S. et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor Schizophr Res 54 2002 281-291
66. Pollmacher T. Haack M. Schuld A. Kraus T. Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks J Psychiatr Res 34 2000 369-382
67. Powell S.B. Geyer M.A. Developmental markers of psychiatric disorders as identified by sensorimotor gating Neurotox Res 4 5-6 2002 489-502
68. Lipska B.K. Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat Dev Brain Res 75 1993 213-222
69. Lipska B.K. Weinberger D.R. Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage Neuropsychopharmacology 10 1994 199-205
70. Lipska B.K. Jaskiw G.E. Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia Neuropsychopharmacology 9 1993 67-75
71. Lipska B.K. Swerdlow N.R. Geyer M.A. Jaskiw G.E. Braff D.L. Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine Psychopharmacology 122 1995 35-43
72. Lieberman J.A. Sheitman B.B. Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity Neuropsychopharmacology 17 1997 205-229
73. O'Donnell P. Lewis B.L. Weinberger D.R. Lipska B.K. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats Cereb Cortex 12 2002 975-982
74. LePen G. Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental models of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol Neuropsychopharmacology 27 2002 1-11
75. Geyer M.A. McIlwain K.L. Paylor R. Mouse genetic models for prepulse inhibition: an early review Mol Psychiatry 7 2002 1039-1053
76. Malberg J.E. Eisch A.J. Nestler E.J. Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus J Neurosci 20 24 2000 9104-9110
77. Geyer M.A. Wilkinson L.S. Humby T. Robbins T.W. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia Biol Psychiatry 34 1993 361-372
78. Jones G.H. Marsden C.A. Robbins T.W. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens Psychopharmacology 102 1990 364-372
79. Jones G.H. Hernandez T.D. Kendall D.A. Marsden C.A. Robbins T.W. Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry Pharmacol Biochem Behav 43 1992 17-35
80. Sahakian B.J. Robbins T.W. Morgan M.J. Iversen S.D. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats Brain Res 84 1975 195-205
81. Bowling S.L. Bardo M.T. Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats Pharmacol Biochem Behav 48 1994 459-464
82. Sahakian B.J. Robbins T.W. Iversen S.D. The effects of isolation rearing on exploration in the rat Anim Learn Behav 5 1997 193-198
83. Hall F.S. Wilkinson L.S. Humby T. Inglis W. Kendall D.A. Marsden C.A. Robbins T.W. Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems Pharmacol Biochem Behav 59 1998 859-872
84. Blanc G. Hervae D. Simon H. Lisoprawski A. Glowinski J. Tassin J.P. Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation Nature 284 1980 265-267
85. Varty G.B. Geyer M.A. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats Behav Neurosci 112 1998 1450-1457
86. Cilia J. Reavill C. Hagan J.J. Jones D.N.C. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats Psychopharmacology 156 2001 327-337
87. Varty G.B. Higgins G.A. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs Psychopharmacology 122 1995 15-26
88. Domeney A. Feldon J. The disruption of prepulse inhibition by social isolation in the Wistar rat: how robust is the effect? Pharmacol Biochem Behav 59 1998 883-890
89. Wilkinson L.S. Killcross S.S. Humby T. Hall F.S. Geyer M.A. Robbins T.W. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition Neuropsychopharmacology 10 1994 61-72
90. Bakshi V.P. Swerdlow N.R. Braff D.L. Geyer M.A. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine Biol Psychiatry 43 1998 436-455
91. Powell S.B. Geyer M.A. Preece M.A. Pitcher L.K. Reynolds G.P. Swerdlow N.R. Dopamine depletion of the nucleus accumbens reverses isolation induced deficits in prepulse inhibition in rats Neuroscience 119 2003 233-240
92. Jones G.H. Robbins T.W. Marsden C.A. Isolation-rearing retards the acquisition of schedule-induced polydipsia in rats Physiol Behav 45 1989 71-77
93. Lapiz M.D. Mateo Y. Parker T. Marsden C. Effects of noradrenaline depletion in the brain on response on novelty in isolation-reared rats Psychopharmacology (Berl) 152 2000 312-320
94. Paulus M.P. Bakshi V.P. Geyer M.A. Isolation rearing affects sequential organization of motor behavior in post-pubertal but not pre-pubertal Lister and Sprague-Dawley rats Behav Brain Res 94 1998 271-280
95. Hall F.S. Humby T. Wilkinson L.S. Robbins T.W. The effects of isolation-rearing on preference by rats for a novel environment Physiol Behav 62 1997 299-303
96. Wang C. McInnis J. Ross-Sanchez M. et al. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia Neurosci 107 2001 535-550
97. Joober R. Zarate J.M. Rouleau G.A. Skamene E. Boksa P. Provisional mapping of quantitative trait loci modulating the acoustic startle response and prepulse inhibition of acoustic startle Neuropsychopharmacology 27 2002 765-781
98. Swerdlow N.R. Shoemaker J.M. Platten A. Pitcher L. Goins J. Auerbach P.P. Heritable differences in the dopaminergic regulation of sensorimotor gating I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny Psychopharmacology (Berl) 2003 available online, DOI: 10.1007/S00213-003-1481-3
99. Swerdlow N.R. Shoemaker J.M. Auerbach P.P. Pitcher L. Goins J. Platten A. Heritable differences in the dopaminergic regulation of sensorimotor gating II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition Psychopharmacology (Berl) 2003 available online, DOI: 10.1007/S00213-003-1480-4
100. Swerdlow N.R. Shoemaker J.M. Platten A. Pitcher L. Goins J. Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains Pharmacol Biochem Behav 75 2003 191-197
101. Francis D.D. Szegda K. Campbell G. Martin W.D. Insel T.R. Epigenetic sources of behavioral differences in mice Nat Neurosci 6 2003 445-446
102. Carter R.J. Lione L.A. Humby T. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation J Neurosci 19 1999 3248-3257
103. Tueting P. Costa E. Dwivedi Y. et al. The phenotypic characteristics of heterozygous reeler mouse Neuroreport 10 6 1999 1329-1334
104. Cohen E. Chow E.W. Weksberg R. Bassett A.S. Phenotype of adults with the 22q11 deletion syndrome: a review Am J Med Genet 86 1999 359-365
105. Liu H. Abecasis G.R. Heath S.C. et al. Genetic variation in the 22q11 locus and susceptibility to schizophrenia Proc Natl Acad Sci USA 99 2002 16859-16864
106. Paylor R. McIlwain K.L. McAninch R. et al. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments Hum Mol Genet 10 2001 2645-2650
107. Gogos J.A. Santha M. Takacs Z. et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice Nat Genet 21 4 1999 434-439
108. Costa E. Davis J. Pesold C. Tueting P. Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics Curr Opin Pharmacol 2 1 2002 56-62
109. Rice D.S. Curran T. Disabled-1 is expressed in type AII amacrine cells in the mouse retina J Comp Neurol 424 2 2000 327-338
110. Fatemi S.H. Earle J.A. McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression Mol Psychiatry 5 6 (654-63) 2000 571
111. Impagnatiello F. Guidotti A.R. Pesold C. et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia Proc Natl Acad Sci USA 95 26 1998 15718-15723
112. Guidotti A. Auta J. Davis J.M. et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study Arch. Gen. Psychiatry 57 11 2000 1061-1069
113. Tremolizzo L. Carboni G. Ruzicka W.B. et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability Proc Natl Acad Sci USA 99 26 2002 17095-17100